Working Groups

EUCROF encourages the initiatives of its Members to form Working Groups (WGs), which represent an open area of discussion on specific areas of interest for Members. Any (Associate) Member can contribute to the WGs by nominating a representative. The WGs meet regularly through TCs and/or face to face meetings. In accordance to the focus of each WG, they are intended to become counterpart/stakeholders for Regulatory Authorities, Industry, Academia and Patients' Associations, write papers in Scientific Journals, actively participate to Congresses/Conferences, thus representing the position and the interests of EUCROF. 

Chair

Antoinette VAN DIJK
Switzerland
Phone: +41 79 51 17 359
Mobile: +39 335 56083680
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 


 

Members

WG Chair: Antoinette van Dijk

WG Members – Vivienne van de Walle (PT&R - The Netherlands), Isabelle Coupienne (Researchlink - Belgium), Ornela Cullufe (CVBF - Albania), Claudine Richon (Popsicube-fovea - France), Sebnem Yasarogullari (MENE Research - Turkey).

Chair

Dagmar CHASE
BVMA
Phone: +49 89 92 92 87 0
Fax: +49 89 92 92 87 50
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

The EUCROF Clinical Trials Legislation Working Group (CTL WG) is aimed to represent European CROs when input is sought from stakeholders by legislators (e.g., EMA, EU Commission) or international organisations (e.g., ICH, WHO) in the context of new provisions for clinical trials. It is crucial that CROs provide their perspectives and opinions as more than 60% of clinical trials are handled by CROs. The delegation of sponsor duties and functions to CROs is important to be taken into account when legal regulations and guidance documents are developed. EUCROF does not miss this chance and continuously participates in the consultation rounds offered by legislators and/or international organisations.

The CTL WG is in operation since more than a decade and has given input to numerous documents with latest activities on the “Management of Clinical Trials under COVID-19 Pandemic”.

It is our mission to effectively use the voice we have through the European CRO Federation.

We are looking forward to continue our active involvement in the development of Clinical Trials documents.

 

Members

WG Chair: Dagmar Chase

WG Members – Ulrike Lorch (Richmond Pharmacology - UK), Simon Lee (Quotient - UK), Eirini Tsante (Next CRO - Greece), Carmen Masanneck (EastHORN - Czech Republic (Germany)), Maria Moumouri (Next CRO - Greece).

Communication

Chair

Christophe GOLENVAUX
BeCRO
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Christophe Golenvaux

WG Members – Darina Hrdličková (ACRO-CZ - Czech Republic), Simon Lee (CCRA - UK), Véronique Marty (AFCROs - France) Juraj Gaplovsky (SACROP - Slovenia), Mariangela Lupo (CVBF - Italy), Ignacio Jimenez (Sermes - Spain), Assia Rosati (EUCROF).

Chair

Harry Therianos

Medical Director - Coronis Research S.A. (Athens, Greece)

Tel.: (+30)210.87.78.000

email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Harry Therianos

WG Members – Maria Bernardo (PPD - Spain), Caridad Fernandez (PPD – Spain), Nadia Zeini (Premier Research - Spain).

Chair

Donato BONIFAZI
Chief Executive Officer - Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF, Italy)

Tel.: +39 080 975 1974
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

WG Chair – Donato Bonifazi

Harsha Basudev (Parexel - Italy), Simone Bucerius (FGK Clinical Research - Germany), Cristina Florescu (Avantyo Institute of Clinical Research - Romania), Manika Kreka (CVBF – Albania), Marta Lettieri (CVBF - Italy), Mariangela Lupo (CVBF - Italy), Marieke Meulemans (GCP Central - The Netherlands), Ana Stoiković (Optimapharm - Croatia), Katerina Tsagaraki (Coronis Research - Greece), Goran Vesov (Optimapharm - Croatia).

 

ET-WG-Flyer_20210205.pptx

Chair

Dolores Pérez Méndez

Sermes CRO, Spain

Phone: +34 608 505 507

 Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Dolores Pérez Méndez

WG Members – Stefan Siegmund (Convidia - Germany) and Rasid Kamal (PPD - Czech Republic).

 

Mission of WG

The goal of this WG is to identify, examine and provide solutions to the principal issues identified in Advanced Therapy Medical Products development and regulation, in constant dialogue and collaboration with the Industry and European Authorities.

 

Main objectives

  • Profiling of EUCROF towards the ATMPs Authorities in EU.
  • Profiling of EUCROF towards the Advanced Therapies industry.
  • Propose solutions to improve the application and assessment process related to ATMPs.

 

Meetings

Meeting by teleconference (Monthly/ every two months)

 

Chair

Alexandre Malouvier

Director Global Data Strategy, Digital Health

Dir Tel: +33 (0)1 41 34 45 59  

Mobile: + 33 (0)6 14 34 72 31

email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair: Alexandre Malouvier


  

WG Co-chair: Denis Comet

WG Members: Liliana Cunha (Clinical Trial & Consulting - Portugal), Remi Gauchon (France), Klairi Liakou (Turkey), Hubert Mechin (Helsia - France), Georgie Nock (pH Associates – UK), Eleni Politi (Greece), Aize Smink (Julius Clinical - The Netherlands), Dana Vankova (IQVIA - Czech Republic).

 

Meetings

Monthly meeting is generally organized through teleconference

Chair

Burcu CEHRELI

Head of Clinical Operations ∙ MENE Research

email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Direct: +90(262) 678 8867 ext:102 
Mobile: +90(507) 812 90 40 
Fax: +90(262) 751 28 38

www.meneresearch.com

 

Members

WG Chair – Ayse Burcu Cehreli

WG Members – Antoinette van Dijk (AICRO – Italy), Franz Josef Binmoeller (SyneosHealth – Germany), Laura Michelini (Italy).

 

pdfEUCROF Medical Device WG Brochure

Chair

Alan Yeomans

Quality Manager 

PCG Solutions AB 

Mobile : +46 70 540 0299 

This email address is being protected from spambots. You need JavaScript enabled to view it. 

Co-Chair 

Yoani Matsakis 

President 

TELEMEDICINE TECHNOLOGIES S.A.S. 

Mobile: +33 6 85 04 57 21

This email address is being protected from spambots. You need JavaScript enabled to view it. 

The group evaluates new technologies that impact the clinical trial environment and evaluates how these can benefit clinical research.

 

Goals

  • Keep EUCROF Members informed on directions in New Technology
  • Technology survey: how much technology can improve clinical trials
  • Position EUCROF as an expert / key stakeholder for the EU regulatory bodies

Members

WG Chair – Alan Yeomans

WG Co-chair – Yoani Matsakis

WG Initiator – Yoani Matsakis

WG Members – Thierry Lepoutre (Lambdaplus – Belgium), Michèle Garot (ClinCellence -Belgium), Isabelle Abousahl (Alcoam By Design – France), Sarah Dubray (ICON - France), Ignacio Jimenz (Sermes – Spain), Keith Berelowitz (Richmond Pharmacology – UK) [Mika Lindroos, Finland - eCF; Fiona Maini, UK - eCF; Dagmar Chase, Germany - REG].

 

Meetings

Webinar meetings are approximately once a month (about 10 times a year).

Face-to-face meetings can be held in conjunction with EUCROF conferences if there is a need.

 

Distribution of Information

  • EUCROF conferences
  • White papers distributed through the EUCROF website
  • Looking into the use of webinars
    • Can be open to members or non-members
    • Can be paying or non-paying webinars
  • Looking into the use of social media
    • EUCROF have an active LinkedIn group which can be used for appropriate information

Chair

Martine DEHLINGER-KREMER
BVMA
Phone: +49 911946469 0
Fax: +49 91194646999
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Martine Dehlinger-Kremer

WG Members – Alex Cvetkovic Muntañola (Syneos – Spain), Sofia Romboli (Zeincro Hellas -  Greece), Jürgen Schäfer (Conreso GmbH – Germany), Donato Bonifazi (CVBF – Italy), Nira Garty (Perfection-CRO Ltd – Israel), Erik Hamminga (Covance - The Netherlands), Ian Vasicka (Co-Investigator/Advisor - Czech Republic), Nuria Martinez-Alier (IQVIA/Advisor – UK), Pavla Nevolova (EastHORN - Czech Republic).

 

pptEUCROF Paediatric WG Brochure

 

Chair

Marta Manso

This email address is being protected from spambots. You need JavaScript enabled to view it.

Business Development

SERMES CRO

 

 

Goals

Fostering actual & confident collaboration with patients in clinical research.

 

  1. Contribute to promote and disseminate best practices of collaboration with patients’ associations involved in study design, run and patient retention in clinical studies.
  2. Ease the effort of CROs having need to involve patients in national and/or international projects.
  3. Ensure involvement of EUCROF as a stakeholder providing consolidated CRO perspectives about the operational collaboration with patients in clinical research. 
  4. Contribute to the recognition by authorities, industry and patients’ advocacy groups of best practices of collaboration with patients in clinical studies and access to innovation.
  5. Create and maintain an annual observatory of patient-centricity experiences and patients associations’ expectations about clinical studies across European countries.

 

Members

WG Members – Marta Manso (Spain), Mariangela Lupo (Italy), Simon Klaasen (The Netherlands), Manika Face Kreka (Albania), Ornela Cullufe (Albania), Hélène Moussu (France).

 

Meetings

Webinar meetings on a monthly base.

Face-to-face meetings.

 

Distribution of Information

  • EUCROF conferences
  • Social media
  • White papers
  • Position papers
  • Publications in journals
  • Scientific conferences
  • Cross communication with patients’ advocacy groups
  • EUCROF website

 

Chair

Nicolas TSIAKKAS
Scientific Director
Medwork Pharma Research & Consulting
5, Chiou st., 164 52 Argyroupoli, Athens, Greece
Phone: +30 210 9960971
Fax: +30 210 9969578

 

 

Co-Chair

Xavier FOURNIE

Corporate Medical Director

Vice-President, Global Medical Affairs - ICON Commercialisation & Outcomes

Phone: +33 (0)4 72 13 66 85

Mobile: +33 (0)6 88 20 00 61

27 rue de la Villette | 69003 LYON | FRANCE

This email address is being protected from spambots. You need JavaScript enabled to view it.

www.ICONplc.com

 

Goals

Position EUCROF PV WG as important conduit and as a reference for stakeholders in the EU pharmacovigilance fora

Main objectives:

  • Cooperation with other EUCROF Working Groups
  • Pro-active Interaction with the Agency
  • Affiliation with relevant stakeholder groups
  • Sharing PV expertise within the EUCROF
  • PV Knowledgebase Build-up and Dissemination

 

Members

 

WG Chair – Nicolas Tsiakkas

WG Co-chair – Xavier Fournie

WG Members – Marco Anelli (Productlife-group – Italy), Zurab Koberidze (FGK-PV – Germany), Essam Ghanem (Vigi-Care – Belgium), Fleming Kjær Jørgensen (Klifo – Denmark).